These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1992138)

  • 1. Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors.
    Sliskovic DR; Picard JA; Roark WH; Roth BD; Ferguson E; Krause BR; Newton RS; Sekerke C; Shaw MK
    J Med Chem; 1991 Jan; 34(1):367-73. PubMed ID: 1992138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.
    Roth BD; Blankley CJ; Chucholowski AW; Ferguson E; Hoefle ML; Ortwine DF; Newton RS; Sekerke CS; Sliskovic DR; Stratton CD
    J Med Chem; 1991 Jan; 34(1):357-66. PubMed ID: 1992137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of cholesterol biosynthesis. 2. 1,3,5-trisubstituted [2-(tetrahydro-4-hydroxy-2-oxopyran-6-yl)ethyl]pyrazoles.
    Sliskovic DR; Roth BD; Wilson MW; Hoefle ML; Newton RS
    J Med Chem; 1990 Jan; 33(1):31-8. PubMed ID: 2296027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents.
    Cai Z; Zhou W; Sun L
    Bioorg Med Chem; 2007 Dec; 15(24):7809-29. PubMed ID: 17851082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and HMG-CoA reductase inhibition of 2-cyclopropyl-4-thiophenyl-quinoline mevalonolactones.
    Zhao S; Zhou W; Liu J
    Bioorg Med Chem; 2009 Dec; 17(23):7915-23. PubMed ID: 19879766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Sliskovic DR; Blankley CJ; Krause BR; Newton RS; Picard JA; Roark WH; Roth BD; Sekerke C; Shaw MK; Stanfield RL
    J Med Chem; 1992 May; 35(11):2095-103. PubMed ID: 1597859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors.
    Suzuki M; Iwasaki H; Fujikawa Y; Kitahara M; Sakashita M; Sakoda R
    Bioorg Med Chem; 2001 Oct; 9(10):2727-43. PubMed ID: 11557359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
    Nakamura CE; Abeles RH
    Biochemistry; 1985 Mar; 24(6):1364-76. PubMed ID: 3886005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Prugh JD; Alberts AW; Deana AA; Gilfillian JL; Huff JW; Smith RL; Wiggins JM
    J Med Chem; 1990 Feb; 33(2):758-65. PubMed ID: 2299642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of cholesterol biosynthesis. 2. 3,5-Dihydroxy-7-(N-pyrrolyl)-6-heptenoates, a novel series of HMG-CoA reductase inhibitors.
    Procopiou PA; Draper CD; Hutson JL; Inglis GG; Ross BC; Watson NS
    J Med Chem; 1993 Nov; 36(23):3658-62. PubMed ID: 8246234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of cholesterol biosynthesis. 1. trans-6-(2-pyrrol-1-ylethyl)-4-hydroxypyran-2-ones, a novel series of HMG-CoA reductase inhibitors. 1. Effects of structural modifications at the 2- and 5-positions of the pyrrole nucleus.
    Roth BD; Ortwine DF; Hoefle ML; Stratton CD; Sliskovic DR; Wilson MW; Newton RS
    J Med Chem; 1990 Jan; 33(1):21-31. PubMed ID: 2296019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.
    Balasubramanian N; Brown PJ; Catt JD; Han WT; Parker RA; Sit SY; Wright JJ
    J Med Chem; 1989 Sep; 32(9):2038-41. PubMed ID: 2769677
    [No Abstract]   [Full Text] [Related]  

  • 14. Phosphorus-containing inhibitors of HMG-CoA reductase. 1. 4-[(2-arylethyl)hydroxyphosphinyl]-3-hydroxy-butanoic acids: a new class of cell-selective inhibitors of cholesterol biosynthesis.
    Karanewsky DS; Badia MC; Ciosek CP; Robl JA; Sofia MJ; Simpkins LM; DeLange B; Harrity TW; Biller SA; Gordon EM
    J Med Chem; 1990 Nov; 33(11):2952-6. PubMed ID: 2231594
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
    Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K
    J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
    Connolly PJ; Westin CD; Loughney DA; Minor LK
    J Med Chem; 1993 Nov; 36(23):3674-85. PubMed ID: 8246237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of bile acid-derived HMG-CoA reductase inhibitors. The role of 21-methyl in recognition of HMG-CoA reductase and the ileal bile acid transport system.
    Wess G; Kramer W; Han XB; Bock K; Enhsen A; Glombik H; Baringhaus KH; Böger G; Urmann M; Hoffmann A
    J Med Chem; 1994 Sep; 37(20):3240-6. PubMed ID: 7932551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives.
    Hoffman WF; Alberts AW; Cragoe EJ; Deana AA; Evans BE; Gilfillan JL; Gould NP; Huff JW; Novello FC; Prugh JD
    J Med Chem; 1986 Feb; 29(2):159-69. PubMed ID: 3950901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives.
    Duggan ME; Alberts AW; Bostedor R; Chao YS; Germershausen JI; Gilfillan JL; Halczenko W; Hartman GD; Hunt V; Imagire JS
    J Med Chem; 1991 Aug; 34(8):2489-95. PubMed ID: 1875346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.